OPCH
Option Care Health, Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- S Feb 27 2 insiders sell $1.2M at $32.20
- B May 4 to May 7 2 days of insider buys: $1.9M by 4 insiders, avg $20.95
- R Jul 29 Option Care Health reported Q2 2026 adjusted diluted EPS of $0.45, a…
- X Sep 30 Short interest falls 29.2% to 8.56M
- R Oct 6 Option Care Health (OPCH) has entered into a definitive merger agree…
- E Oct 6 Trading halt: Trading Halt: OPCH — T1 (News Pending)
- R Oct 6 Option Care Health has entered into a definitive agreement to be acq…
- A Oct 7 5 downgrades
Signal stack
Where each data set points today.
- InsidersMIXED
4 insiders bought $1.9M at an average $20.95. 2 insiders sold $1.2M. Price is 49% above their cost.
- InstitutionsMIXED
Q2 2026: 40 added (1 new), 29 trimmed or exited. Largest new: Storebrand Asset Management As $14.1M.
- AnalystsBULLISH
13 of 19 rate it Buy or better. Median target $32.05 (+3%).
- Short sellersCOVERING
Short interest −29.2% to 8.56M shares. 3.5 days to cover, ≈5.7% of shares.
- TrendUPTREND
21% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $125.4M |
| DIMENSIONAL FUND ADVISORS LP | ADD | $114.3M |
| MILLENNIUM MANAGEMENT LLC | ADD | $54.9M |
| GOLDMAN SACHS GROUP INC | ADD | $45.4M |
| FMR LLC | TRIM | $38.1M |
| Point72 Asset Management, L.P. | DOUBLED | $37.8M |
| CITADEL ADVISORS LLC | TRIM | $34.3M |
| UBS Group AG | ADD | $26.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
19 analystsPrice is inside the target range. Median implies +3%.Targets as of Oct 26, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 9, 2026 | UBS DOWNGRADE | Neutral |
| Oct 7, 2026 | William Blair DOWNGRADE | Market Perform |
| Oct 7, 2026 | JP Morgan DOWNGRADE | Neutral |
| Oct 7, 2026 | Citizens DOWNGRADE | Market Perform |
| Oct 7, 2026 | Jefferies DOWNGRADE | Hold |
| Oct 7, 2026 | Barrington Research DOWNGRADE | Market Perform |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 6, 2026 | Bhatia Prateek EVP Sp Sales & Solutions | AWARD | 16,386 sh |
| Jul 6, 2026 | Bhatia Prateek EVP Sp Sales & Solutions | AWARD | 23,409 sh |
| May 20, 2026 | BRANDT ERIC Director | AWARD | $58.8K |
| May 20, 2026 | SULLIVAN TIMOTHY P Director | AWARD | $107.5K |
| May 20, 2026 | KRAEMER HARRY M JANSEN JR Director | AWARD | $268.5K |
| May 20, 2026 | Deckmann Natasha Director | AWARD | $18.8K |
| May 20, 2026 | BRANDT ERIC Director | AWARD | 8,997 sh |
| May 20, 2026 | Wright Norman L. Director | AWARD | 8,997 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Sep 30, 2026| Oct 6, 2026 | Resumption Scheduled | Resumed |
SecBot reports
11 filings · 1 press release · 3 bullish · 0 bearish · 1 mixed · 7 neutral- NEUTRAL DEFA14AOct 6, 2026
Option Care Health filed DEFA14A soliciting materials in connection with its pending acquisition…
Monitor for the filing of the definitive proxy statement and the stockholder vote timeline. The key catalyst is regulatory approval and the shareholder meeting date — any delays or antitrust…
- BULLISH DEFA14AOct 6, 2026
Option Care Health (OPCH) has entered into a definitive merger agreement to be acquired by an…
The deal is fully financed with committed equity and debt, and the closing is not conditioned on financing — reducing execution risk. Key catalysts to watch: stockholder vote, HSR clearance, and…
- BULLISH 8-KOct 6, 2026
Option Care Health has entered into a definitive agreement to be acquired by an investor group led…
Monitor for stockholder vote timing and regulatory clearances (HSR, state healthcare approvals) as key catalysts toward the expected H1 2027 close. The spread to the $32.05 deal price will reflect…
- BULLISH 8-KJul 29, 2026
Option Care Health reported Q2 2026 adjusted diluted EPS of $0.45, a 9.8% YoY increase and a 5.4%…
The EPS beat and raised guidance floor are positive, but the 1.9% revenue growth and narrowed EBITDA guidance suggest limited acceleration. Monitor the Q3 sequential revenue growth commentary for…
All OPCH filing & press-release reports (12)
- DEFA14A reportOct 6, 2026
- DEFA14A reportOct 6, 2026
- 8-K reportOct 6, 2026
- 8-K reportJul 29, 2026
- COURT-RULING reportMar 30, 2026
- PRESS-RELEASE reportJun 4, 2026
- 8-K reportMay 12, 2026
- CLUSTER reportMay 4, 2026
- CLUSTER reportMay 4, 2026
- CLUSTER reportMay 4, 2026
- DEFA14A reportApr 8, 2026
- PRESS-RELEASE reportApr 8, 2026